These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8991797)
1. Attenuation of memory with Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog with high affinity for mu-opioid receptors. Ukai M; Kobayashi T; Mori K; Shinkai N; Sasaki Y; Kameyama T Eur J Pharmacol; 1995 Dec; 287(3):245-9. PubMed ID: 8991797 [TBL] [Abstract][Full Text] [Related]
2. Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog, impairs memory consolidation in mice. Ukai M; Mori K; Hashimoto S; Kobayashi T; Sasaki Y; Kameyama T Eur J Pharmacol; 1993 Aug; 239(1-3):237-40. PubMed ID: 7901029 [TBL] [Abstract][Full Text] [Related]
3. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors. Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815 [TBL] [Abstract][Full Text] [Related]
4. Effects of Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog, on elevated plus-maze learning and spontaneous alternation performance in mice. Ukai M; Monma J; Shinkai N; Sasaki Y; Kameyama T Gen Pharmacol; 1997 Sep; 29(3):453-6. PubMed ID: 9378255 [TBL] [Abstract][Full Text] [Related]
5. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA. Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280 [TBL] [Abstract][Full Text] [Related]
6. Endomorphins 1 and 2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in mice. Ukai M; Watanabe Y; Kameyama T Eur J Pharmacol; 2001 Jun; 421(2):115-9. PubMed ID: 11399267 [TBL] [Abstract][Full Text] [Related]
8. Antinociceptive and behavioral effects of synthetic deltorphin analogs. Negri L; Noviello L; Noviello V Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471 [TBL] [Abstract][Full Text] [Related]
9. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA. Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162 [TBL] [Abstract][Full Text] [Related]
10. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors. Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845 [TBL] [Abstract][Full Text] [Related]
11. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice. Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344 [TBL] [Abstract][Full Text] [Related]
12. Identification of the opioid receptors involved in passive-avoidance learning in the day-old chick during the second wave of neuronal activity. Freeman FM; Young IG Brain Res; 2000 May; 864(2):230-9. PubMed ID: 10802030 [TBL] [Abstract][Full Text] [Related]
13. Differential involvement of mu 1-opioid receptors in dermorphin tetrapeptide analogues-induced antinociception. Mizoguchi H; Yuhki M; Watanabe H; Hayashi T; Sakurada C; Yonezawa A; Sakurada T; Sakurada S Eur J Pharmacol; 2004 Feb; 486(1):19-24. PubMed ID: 14751403 [TBL] [Abstract][Full Text] [Related]
14. Lack of a rewarding effect and a locomotor-enhancing effect of the selective μ-opioid receptor agonist amidino-TAPA. Mizoguchi H; Watanabe C; Osada S; Yoshioka M; Aoki Y; Natsui S; Yonezawa A; Kanno S; Ishikawa M; Sakurada T; Sakurada S Psychopharmacology (Berl); 2010 Oct; 212(2):215-25. PubMed ID: 20683583 [TBL] [Abstract][Full Text] [Related]
15. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding. Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727 [TBL] [Abstract][Full Text] [Related]
17. Involvement of mouse μ-opioid receptor splice variants in the spinal antinociception induced by the dermorphin tetrapeptide analog amidino-TAPA. Mizoguchi H; Watanabe C; Higashiya T; Takeda S; Moriyama K; Yonezawa A; Sato T; Komatsu T; Sakurada T; Sakurada S Eur J Pharmacol; 2011 Jan; 651(1-3):66-72. PubMed ID: 21047509 [TBL] [Abstract][Full Text] [Related]
18. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor. Amiche M; Sagan S; Mor A; Delfour A; Nicolas P Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911 [TBL] [Abstract][Full Text] [Related]
20. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay. Sterious SN; Walker EA J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]